Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cells.

Farrell CJ, Zaupa C, Barnard Z, Maley J, Martuza RL, Rabkin SD, Curry WT Jr.

Clin Cancer Res. 2008 Dec 1;14(23):7711-6. doi: 10.1158/1078-0432.CCR-08-1364.

2.

Cancer immunotherapy using in vitro genetically modified targeted dendritic cells.

Wei H, Wang H, Lu B, Li B, Hou S, Qian W, Fan K, Dai J, Zhao J, Guo Y.

Cancer Res. 2008 May 15;68(10):3854-62. doi: 10.1158/0008-5472.CAN-07-6051.

3.

Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation.

Lapteva N, Seethammagari MR, Hanks BA, Jiang J, Levitt JM, Slawin KM, Spencer DM.

Cancer Res. 2007 Nov 1;67(21):10528-37.

4.

E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.

Kim J, Kim JH, Choi KJ, Kim PH, Yun CO.

Hum Gene Ther. 2007 Sep;18(9):773-86.

PMID:
17725410
5.

Dendritic cell vaccination.

Proudfoot O, Pouniotis D, Sheng KC, Loveland BE, Pietersz GA.

Expert Rev Vaccines. 2007 Aug;6(4):617-33. Review.

PMID:
17669014
6.

Optimizing dendritic cell-based immunotherapy for cancer.

Zhong H, Shurin MR, Han B.

Expert Rev Vaccines. 2007 Jun;6(3):333-45.

PMID:
17542749
7.

Cytokine gene transfer for cancer therapy.

Podhajcer OL, Lopez MV, Mazzolini G.

Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):183-94. Epub 2007 Feb 21. Review.

PMID:
17320465
8.

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.

Clin Cancer Res. 2006 Oct 1;12(19):5859-68.

9.

Dendritic cells and tumor microenvironment: a dangerous liaison.

Fricke I, Gabrilovich DI.

Immunol Invest. 2006;35(3-4):459-83. Review.

10.

Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.

Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H, Cho S, Sohn JH, Kim GE, Yun CO.

Gene Ther. 2006 Jul;13(13):1010-20. Epub 2006 Mar 9.

PMID:
16525479
11.

Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency.

Gervais A, Levêque J, Bouet-Toussaint F, Burtin F, Lesimple T, Sulpice L, Patard JJ, Genetet N, Catros-Quemener V.

Breast Cancer Res. 2005;7(3):R326-35. Epub 2005 Feb 25.

12.
13.

TNF/TNFR family members in costimulation of T cell responses.

Watts TH.

Annu Rev Immunol. 2005;23:23-68. Review.

PMID:
15771565
14.

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.

Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH.

Cancer Gene Ther. 2005 Jan;12(1):61-71.

PMID:
15375379
15.

Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

Dummer R, Hassel JC, Fellenberg F, Eichmüller S, Maier T, Slos P, Acres B, Bleuzen P, Bataille V, Squiban P, Burg G, Urosevic M.

Blood. 2004 Sep 15;104(6):1631-8. Epub 2004 May 25.

17.

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

Sangro B, Mazzolini G, Ruiz J, Herraiz M, Quiroga J, Herrero I, Benito A, Larrache J, Pueyo J, Subtil JC, Olagüe C, Sola J, Sádaba B, Lacasa C, Melero I, Qian C, Prieto J.

J Clin Oncol. 2004 Apr 15;22(8):1389-97.

18.
19.

E1A gene therapy inhibits angiogenesis in a Ewing's sarcoma animal model.

Zhou Z, Zhou RR, Guan H, Bucana CD, Kleinerman ES.

Mol Cancer Ther. 2003 Dec;2(12):1313-9.

20.

Dendritic cells: a journey from laboratory to clinic.

Cerundolo V, Hermans IF, Salio M.

Nat Immunol. 2004 Jan;5(1):7-10. Review. No abstract available.

PMID:
14699398
Items per page

Supplemental Content

Write to the Help Desk